{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:34:32Z","timestamp":1787636072651,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Stichting Alzheimer Onderzoek","award":["20220007"],"award-info":[{"award-number":["20220007"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST874\/9-1"],"award-info":[{"award-number":["INST874\/9-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Dementia Research Institute at UCL"},{"name":"UK NIHR UCLH Biomedical Research Centre"},{"name":"Dominantly Inherited Alzheimer Network"},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G008023N"],"award-info":[{"award-number":["G008023N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01896-3","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:55:48Z","timestamp":1764168948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The relationship between amyloid-\u03b2 peptide spectrum and the spastic paraparesis phenotype in autosomal dominant Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-3465","authenticated-orcid":false,"given":"Katarzyna Marta","family":"Zoltowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1104-7232","authenticated-orcid":false,"given":"Julia","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6383-4147","authenticated-orcid":false,"given":"Mohamed Belal","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-4090","authenticated-orcid":false,"given":"Thomas","family":"Enzlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-6451","authenticated-orcid":false,"given":"Carsten","family":"Hopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0361-7455","authenticated-orcid":false,"given":"Natalie S.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8239-559X","authenticated-orcid":false,"given":"Luc\u00eda","family":"Ch\u00e1vez-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"1896_CR1","doi-asserted-by":"crossref","unstructured":"Ch\u00e1vez-Guti\u00e9rrez L, Szaruga M. Mechanisms of neurodegeneration\u2014Insights from familial Alzheimer\u2019s disease. In: Seminars in cell & developmental biology: 2020. Elsevier: 75\u201385.","DOI":"10.1016\/j.semcdb.2020.03.005"},{"issue":"13","key":"1896_CR2","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/S1474-4422(16)30193-4","volume":"15","author":"NS Ryan","year":"2016","unstructured":"Ryan NS, Nicholas JM, Weston PSJ, Liang Y, Lashley T, Guerreiro R, et al. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer\u2019s disease: a case series. Lancet Neurol. 2016;15(13):1326\u201335. https:\/\/doi.org\/10.1016\/S1474-4422(16)30193-4.","journal-title":"Lancet Neurol"},{"issue":"41","key":"1896_CR3","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","volume":"29","author":"M Takami","year":"2009","unstructured":"Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S, et al. Gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci. 2009;29(41):13042\u201352. https:\/\/doi.org\/10.1523\/JNEUROSCI.2362-09.2009.","journal-title":"J Neurosci"},{"issue":"1","key":"1896_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/alz.12646","volume":"19","author":"L Liu","year":"2023","unstructured":"Liu L, Lauro BM, He A, Lee H, Bhattarai S, Wolfe MS, et al. Identification of the Abeta37\/42 peptide ratio in CSF as an improved Abeta biomarker for Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(1):79\u201396. https:\/\/doi.org\/10.1002\/alz.12646.","journal-title":"Alzheimers Dement."},{"issue":"6","key":"1896_CR5","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1038\/s41380-022-01518-6","volume":"27","author":"D Petit","year":"2022","unstructured":"Petit D, Fernandez SG, Zoltowska KM, Enzlein T, Ryan NS, O\u2019Connor A, et al. A\u03b2 profiles generated by Alzheimer\u2019s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset. Mol Psychiatry. 2022;27(6):2821\u201332. https:\/\/doi.org\/10.1038\/s41380-022-01518-6.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"1896_CR6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S1474-4422(24)00236-9","volume":"23","author":"SA Schultz","year":"2024","unstructured":"Schultz SA, Liu L, Schultz AP, Fitzpatrick CD, Levin R, Bellier JP, et al. \u03b3-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer\u2019s disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol. 2024;23(9):913\u201324. https:\/\/doi.org\/10.1016\/S1474-4422(24)00236-9.","journal-title":"Lancet Neurol"},{"issue":"10","key":"1896_CR7","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/emboj.2012.79","volume":"31","author":"L Chavez-Gutierrez","year":"2012","unstructured":"Chavez-Gutierrez L, Bammens L, Benilova I, Vandersteen A, Benurwar M, Borgers M, et al. The mechanism of gamma-Secretase dysfunction in familial Alzheimer disease. EMBO J. 2012;31(10):2261\u201374. https:\/\/doi.org\/10.1038\/emboj.2012.79.","journal-title":"EMBO J"},{"issue":"12","key":"1896_CR8","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1084\/jem.20150892","volume":"212","author":"M Szaruga","year":"2015","unstructured":"Szaruga M, Veugelen S, Benurwar M, Lismont S, Sepulveda-Falla D, Lleo A, et al. Qualitative changes in human gamma-secretase underlie familial Alzheimer\u2019s disease. J Exp Med. 2015;212(12):2003\u201313. https:\/\/doi.org\/10.1084\/jem.20150892.","journal-title":"J Exp Med"},{"issue":"3","key":"1896_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cell.2017.07.004","volume":"170","author":"M Szaruga","year":"2017","unstructured":"Szaruga M, Munteanu B, Lismont S, Veugelen S, Horr\u00e9 K, Mercken M, et al. Alzheimer\u2019s-causing mutations Shift A\u03b2 length by destabilizing \u03b3-Secretase-A\u03b2n interactions. Cell. 2017;170(3):443\u201356. https:\/\/doi.org\/10.1016\/j.cell.2017.07.004.","journal-title":"Cell"},{"issue":"2","key":"1896_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jfma.2015.08.004","volume":"115","author":"YF Shea","year":"2016","unstructured":"Shea YF, Chu LW, Chan AO, Ha J, Li Y, Song YQ. A systematic review of familial Alzheimer\u2019s disease: differences in presentation of clinical features among three mutated genes and potential ethnic differences. J Formos Med Assoc. 2016;115(2):67\u201375. https:\/\/doi.org\/10.1016\/j.jfma.2015.08.004.","journal-title":"J Formos Med Assoc"},{"issue":"13","key":"1896_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S1474-4422(16)30229-0","volume":"15","author":"M Tang","year":"2016","unstructured":"Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, et al. Neurological manifestations of autosomal dominant familial Alzheimer\u2019s disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol. 2016;15(13):1317\u201325. https:\/\/doi.org\/10.1016\/S1474-4422(16)30229-0.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1896_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12186","volume":"13","author":"V Chelban","year":"2021","unstructured":"Chelban V, Breza M, Szaruga M, Vandrovcova J, Murphy D, Lee CJ, et al. Spastic paraplegia preceding PSEN1-related familial Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2021;13(1):e12186. https:\/\/doi.org\/10.1002\/dad2.12186.","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"1896_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.721047","volume":"14","author":"JF Vazquez-Costa","year":"2021","unstructured":"Vazquez-Costa JF, Paya-Montes M, Martinez-Molina M, Jaijo T, Szymanski J, Mazon M, et al. Presenilin-1 mutations are a cause of primary lateral sclerosis-like syndrome. Front Mol Neurosci. 2021;14:721047. https:\/\/doi.org\/10.3389\/fnmol.2021.721047.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"1896_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00832-1","volume":"20","author":"SG Fernandez","year":"2025","unstructured":"Fernandez SG, Oria CG, Petit D, Annaert W, Ringman JM, Fox NC, et al. Spectrum of \u03b3-secretase dysfunction as a unifying predictor of ADAD age at onset across PSEN1, PSEN2 and APP causal genes. Mol Neurodegener. 2025;20(1):48. https:\/\/doi.org\/10.1186\/s13024-025-00832-1.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"1896_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.neuron.2016.03.010","volume":"90","author":"S Veugelen","year":"2016","unstructured":"Veugelen S, Saito T, Saido TC, Chavez-Gutierrez L, De Strooper B. Familial Alzheimer\u2019s disease mutations in presenilin generate amyloidogenic Abeta peptide seeds. Neuron. 2016;90(2):410\u20136. https:\/\/doi.org\/10.1016\/j.neuron.2016.03.010.","journal-title":"Neuron"},{"issue":"10","key":"1896_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jmg.2005.033456","volume":"42","author":"G Raux","year":"2005","unstructured":"Raux G, Guyant-Marechal L, Martin C, Bou J, Penet C, Brice A, et al. Molecular diagnosis of autosomal dominant early onset Alzheimer\u2019s disease: an update. J Med Genet. 2005;42(10):793\u20135. https:\/\/doi.org\/10.1136\/jmg.2005.033456.","journal-title":"J Med Genet"},{"issue":"2","key":"1896_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.12740\/PP\/OnlineFirst\/114122","volume":"55","author":"B Labuz-Roszak","year":"2021","unstructured":"Labuz-Roszak B, Torbus-Paluszczak M, Becelewski J, Becelewski M, Dobrakowski P, Pierzchala K. Early onset Alzheimer\u2019s disease - a case study. Psychiatr Pol. 2021;55(2):323\u201330. https:\/\/doi.org\/10.12740\/PP\/OnlineFirst\/114122.","journal-title":"Psychiatr Pol."},{"issue":"5","key":"1896_CR18","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/s0197-4580(02)00192-6","volume":"24","author":"J Miklossy","year":"2003","unstructured":"Miklossy J, Taddei K, Suva D, Verdile G, Fonte J, Fisher C, et al. Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer\u2019s disease. Neurobiol Aging. 2003;24(5):655\u201362. https:\/\/doi.org\/10.1016\/s0197-4580(02)00192-6.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1896_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14802\/jmd.17066","volume":"11","author":"S Appel-Cresswell","year":"2018","unstructured":"Appel-Cresswell S, Guella I, Lehman A, Foti D, Farrer MJ. PSEN1 p.Met233Val in a complex neurodegenerative movement and neuropsychiatric disorder. Journal of Movement Disorders. 2018;11(1):45\u20138. https:\/\/doi.org\/10.14802\/jmd.17066.","journal-title":"Journal of Movement Disorders"},{"issue":"9","key":"1896_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098417","volume":"24","author":"Y Yang","year":"2023","unstructured":"Yang Y, Bagyinszky E, An SSA. Presenilin-1 (PSEN1) mutations: clinical phenotypes beyond Alzheimer\u2019s disease. Int J Mol Sci. 2023;24(9):8417. https:\/\/doi.org\/10.3390\/ijms24098417.","journal-title":"Int J Mol Sci"},{"key":"1896_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"NV Chawla","year":"2002","unstructured":"Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321\u201357.","journal-title":"J Artif Intell Res"},{"issue":"24","key":"1896_CR22","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1021\/acs.analchem.3c05557","volume":"96","author":"T Enzlein","year":"2024","unstructured":"Enzlein T, Lashley T, Sammour DA, Hopf C, Chavez-Gutierrez L. Integrative single-plaque analysis reveals signature Abeta and lipid profiles in the Alzheimer\u2019s brain. Anal Chem. 2024;96(24):9799\u2013807. https:\/\/doi.org\/10.1021\/acs.analchem.3c05557.","journal-title":"Anal Chem"},{"key":"1896_CR23","doi-asserted-by":"crossref","unstructured":"Kretner B, Trambauer J, Fukumori A, Mielke J, Kuhn P-H, Kremmer E, Giese A, Lichtenthaler SF, Haass C, Arzberger T. Generation and deposition of A? 43 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer's disease. 2016.","DOI":"10.15252\/emmm.201505952"},{"issue":"8","key":"1896_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nn.2858","volume":"14","author":"T Saito","year":"2011","unstructured":"Saito T, Suemoto T, Brouwers N, Sleegers K, Funamoto S, Mihira N, et al. Potent amyloidogenicity and pathogenicity of Abeta43. Nat Neurosci. 2011;14(8):1023\u201332. https:\/\/doi.org\/10.1038\/nn.2858.","journal-title":"Nat Neurosci"},{"issue":"7","key":"1896_CR25","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1002\/alz.13904","volume":"20","author":"C Arber","year":"2024","unstructured":"Arber C, Belder CRS, Tomczuk F, Gabriele R, Buhidma Y, Farrell C, et al. The presenilin 1 mutation P436S causes familial Alzheimer\u2019s disease with elevated Abeta43 and atypical clinical manifestations. Alzheimers Dement. 2024;20(7):4717\u201326. https:\/\/doi.org\/10.1002\/alz.13904.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1896_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac321","volume":"5","author":"N Willumsen","year":"2023","unstructured":"Willumsen N, Arber C, Lovejoy C, Toombs J, Alatza A, Weston PSJ, et al. The PSEN1 E280G mutation leads to increased amyloid-\u03b243 production in induced pluripotent stem cell neurons and deposition in brain tissue. Brain Commun. 2023;5(1):fcac321. https:\/\/doi.org\/10.1093\/braincomms\/fcac321.","journal-title":"Brain Commun"},{"key":"1896_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(00)83282-0","volume":"21","author":"JA Hardy","year":"2000","unstructured":"Hardy JA, Houlden H, Baker M, McGowan E, Lewis P, Prihar G, et al. High A42 causing presenilin 1 mutations lead to the cotton wool plaques\/spastic paraparesis variant of Alzheimer\u2019s disease. Neurobiol Aging. 2000;21:212.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1896_CR28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F","volume":"48","author":"H Houlden","year":"2000","unstructured":"Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R, et al. Variant Alzheimer\u2019s disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol. 2000;48(5):806\u20138.","journal-title":"Ann Neurol"},{"issue":"11","key":"1896_CR29","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/jnen\/60.11.1051","volume":"60","author":"TV Le","year":"2001","unstructured":"Le TV, Crook R, Hardy J, Dickson DW. Cotton wool plaques in non-familial late-onset Alzheimer disease. J Neuropathol Exp Neurol. 2001;60(11):1051\u201361. https:\/\/doi.org\/10.1093\/jnen\/60.11.1051.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"1896_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00401-003-0737-7","volume":"106","author":"O Yokota","year":"2003","unstructured":"Yokota O, Terada S, Ishizu H, Ujike H, Ishihara T, Namba M, et al. Variability and heterogeneity in Alzheimer\u2019s disease with cotton wool plaques: a clinicopathological study of four autopsy cases. Acta Neuropathol. 2003;106(4):348\u201356. https:\/\/doi.org\/10.1007\/s00401-003-0737-7.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1896_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3233\/JAD-151052","volume":"51","author":"CH Lyoo","year":"2016","unstructured":"Lyoo CH, Cho H, Choi JY, Hwang MS, Hong SK, Kim YJ, et al. Tau accumulation in primary motor cortex of variant Alzheimer\u2019s disease with spastic paraparesis. J Alzheimers Dis. 2016;51(3):671\u20135. https:\/\/doi.org\/10.3233\/JAD-151052.","journal-title":"J Alzheimers Dis"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01896-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01896-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01896-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:56:00Z","timestamp":1764168960000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01896-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1896"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01896-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KMZ, JB, MBH, TE, CH and NSR declare no competing interests. LGC is scientific founder of TRIM and reports consultancy for Roche and Astex Pharmaceuticals in the last 3\u00a0years.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}